Transcriptome profiles of tumors from 105K Tsc2-null cancer cells grown in C57BL/6J mice and treated with vehicle control, rapamycin and/or loratadine

Characterization of the inhibitory effect of loratadine in monotherapy and combined with rapamycin on 105K Tsc2-null tumors. Overall design: RNA sequencing of bulk mouse mammary tumors.

氯雷他定（loratadine）单药及联合雷帕霉素（rapamycin）对105K株Tsc2-null型肿瘤的抑制效应表征。实验设计概述：对小鼠实体乳腺肿瘤组织开展批量RNA测序 (RNA sequencing)。